CSO
Decoy Therapeutics
Winchester, Massachusetts
Barbara brings 25 years of leadership experience in pharma and biotech to bear on new drug discovery. During her time at Bayer Pharmaceuticals she helped establish a new oncology department, and served as discovery co-project leader for sorafenib, later approved for kidney and liver cancers. Successive leadership positions at Chiron, Millennium Pharmaceuticals and Takeda consolidated a very broad-based expertise in advancing large and small molecule projects to and through clinical trials, including ixazomib for multiple myeloma. Barb has deep experience on clinical development teams and a solid understanding of what it takes to get a drug approved. Over her career Barb has built many teams, from large departments to small specialty groups, and now as a co-founder of the infectious disease startup Decoy Therapeutics. Barb is passionate about bringing globally accessible new therapeutic peptide conjugates to bear on viral respiratory diseases and GPCR based indications.
Disclosure information not submitted.
Monday, May 5, 2025
8:00 AM - 9:30 AM ET